1. Home
  2. SHIM vs TNYA Comparison

SHIM vs TNYA Comparison

Compare SHIM & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$4.14

Market Cap

160.8M

Sector

N/A

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.70

Market Cap

168.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
TNYA
Founded
1990
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.8M
168.2M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
SHIM
TNYA
Price
$4.14
$0.70
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
86.3K
2.1M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
81.95
54.96
EPS
N/A
N/A
Revenue
$492,844,000.00
N/A
Revenue This Year
$13.99
N/A
Revenue Next Year
$6.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.63
N/A
52 Week Low
$1.95
$0.53
52 Week High
$6.76
$2.35

Technical Indicators

Market Signals
Indicator
SHIM
TNYA
Relative Strength Index (RSI) 54.86 44.01
Support Level $4.05 $0.65
Resistance Level $4.09 $0.81
Average True Range (ATR) 0.28 0.04
MACD 0.01 -0.00
Stochastic Oscillator 41.95 37.35

Price Performance

Historical Comparison
SHIM
TNYA

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: